Skip to main content
OpenTrials
Completed

NCT Number: NCT03676738

Cohort Study of Risk Factors for Postoperative Cognitive Decline

Presently, the role of either genetic factors or biological sex in the development of postoperative cognitive dysfunction (POCD) is unknown. There is a critical need to determine which individuals are at high-risk for developing POCD by virtue of biological sex or genetic predisposition. The knowledge gained in the described research has the potential to shed light on mechanistic pathways, a necessary next step in order to ultimately identify therapeutic strategies.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year–89 year

Sex eligibility

All sexes

Study type

Observational

Primary location

OHSU

Portland, Oregon, 97239, United States

About this study

Adults 65 years and older represent the fastest-growing age group in the United States, and account for one third of all surgical patients. These older adults are at the highest risk for deleterious postoperative neurocognitive outcomes. Postoperative cognitive dysfunction (POCD) occurs in up to 40% of older adults after major non-cardiac surgery. POCD is a syndrome characterized by a decrease in performance on neuropsychological test battery from before to after surgery. Neuropsychological testing for POCD typically spans cognitive domains including memory, attention, concentration, and/or executive function. There is an increasing body of literature suggesting that exposure to surgery and anesthesia increases the risk of Alzheimer's disease (AD). Surgery and anesthesia enhance neuropathologic changes known to underlie AD including amyloid beta accumulation and aggregation, neuroinflammation, increased levels of tau and tau phosphorylation, and memory decline. However, not everyone with a history of surgery and anesthesia develops POCD, suggesting biological risk factors are involved.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Scheduled for an in-patient, elective spine surgery where subject will receive general anesthesia
  • Presenting to spine clinic and undergoing conservative, non-surgical management of spine disorder
  • Subjects must have sufficient vision and hearing to complete neuropsychological testing
  • Proficient in spoken and written English language

Exclusion criteria

  • Diagnosed dementia or dementia-related treatment (i.e. donepezil prescription, or memory-care facility residence)
  • Significant disease of the central nervous system (CNS) (i.e. Parkinson's disease)
  • History of stroke or traumatic brain injury
  • Major psychiatric disorder (i.e. schizophrenia)
  • Alcohol or drug abuse according to DSM-V within the last 2 years
  • Need for urgent/emergent surgery
  • Surgery/anesthesia within prior 12 months
  • Refusal of consent

Treatment and study plan

Primary outcomes

  1. Genetic Variables

    Time frame: Six months

    To determine whether specific genetic variables (i.e. APOE4 or PLA2 alleles) and/or biological sex confer a higher risk to developing postoperative cognitive and functional status decline in older adults.

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Registry information

Acronym: POCD

Important dates

Study start
2018
Primary completion
2022
Study completion
2022
First posted
Sep 19, 2018
Registry last updated
May 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.